Knowledge & Support · Pharmacy Board
Pharmacy Board of Australia Complaints and Notifications Explained
A notification to the regulator is one of the most stressful things a pharmacist can face. This guide explains, in plain English, how concerns about pharmacists are handled in Australia — who deals with them, what the Pharmacy Board can and cannot do, and how the process usually unfolds.
Key takeaways
- Concerns about pharmacists are called notifications; in most of Australia Ahpra manages them on behalf of the Pharmacy Board of Australia.
- In NSW the Pharmacy Council of NSW handles them, and in Queensland concerns go first to the Office of the Health Ombudsman.
- Dispensing and labelling errors, drugs-and-poisons breaches and medication misadventure are common pharmacist triggers.
- The Board is a risk-based, public-protection regulator — many notifications close without any restriction on registration.
- Documenting the incident early, taking advice, and showing insight and remediation are the keys to responding well.
Who regulates pharmacists?
Pharmacy is regulated nationally by the Pharmacy Board of Australia, working with Ahpra under the Health Practitioner Regulation National Law. Ahpra receives and manages concerns on the Board’s behalf, but the Board makes the decisions. In New South Wales concerns are handled by the Pharmacy Council of NSW (with the Health Care Complaints Commission), and in Queensland they go first to the Office of the Health Ombudsman, which decides what to refer on.
What triggers a notification about a pharmacist?
A notification is a concern about a pharmacist’s health, conduct or performance. For pharmacists the common triggers are distinctive: dispensing and labelling errors, breaches of drugs-and-poisons legislation, medication misadventure, supply or record-keeping problems, privacy breaches, and conduct concerns. Anyone can raise a notification, and pharmacists, employers and education providers have a duty to make a mandatory notification where they reasonably believe notifiable conduct has occurred.
What happens after a notification is made?
The concern is first assessed — usually within around 60 days — and you are generally given the chance to respond. From there the Board may take no further action, ask for more information, refer the matter to a health or performance pathway, open a formal investigation, or, only where the public is at serious and current risk, take immediate action on your registration.
Possible outcomes
Outcomes run from no further action, through a caution, undertaking or conditions on registration, to referral to a panel or tribunal in the most serious cases. Where a dispensing error is a one-off in an otherwise sound practice, the Board is far more interested in whether you have understood and corrected the underlying cause than in punishment.
Responding well
- Document early. Make a factual incident note as soon as an error or complaint comes to light — a notification can arrive months later, and your contemporaneous record will matter.
- Get advice. Contact your professional indemnity insurer or the Pharmacists’ Defence Limited (PDL), and avoid informal discussions with investigators; nothing said to an investigator is unrecorded.
- Show insight and remediation. Evidence of what you have changed — systems, checking steps, workload — is often the most persuasive part of a response.
Our umbrella guides explain the system in more depth: what an Ahpra notification is and how to respond to one.
Related CPD courses
Prepare and respond with confidence using CPD designed for Australian practitioners:
CPD courseDealing with a Complaint or Investigation Professionally CPD courseFitness to Practise for Healthcare Professionals CPD courseInsight for Fitness to Practise CPD courseRemediation for Fitness to PractiseContinue the Pharmacy Board series
Dispensing Errors and Professional Accountability for Pharmacists Documentation and Medicine Safety for PharmacistsSources and further reading
The regulator’s own documents this guide is written from. Read them alongside it; they are the standard a Board applies.
- Pharmacy Board of Australia — Codes, guidelines and policieshttps://www.pharmacyboard.gov.au/codes-guidelines
- Ahpra — Shared Code of conducthttps://www.ahpra.gov.au/Resources/Code-of-conduct/Shared-Code-of-conduct.aspx
- Ahpra — How we manage concernshttps://www.ahpra.gov.au/Notifications/How-we-manage-concerns.aspx
- Ahpra — National Law amendments (2022 and 2025)https://www.ahpra.gov.au/About-Ahpra/Ministerial-Directives-and-Communiques/National-Law-amendments/
Frequently asked questions
Who manages complaints about pharmacists?
In most of Australia Ahpra manages notifications on behalf of the Pharmacy Board. In New South Wales it is the Pharmacy Council of NSW, and in Queensland concerns go first to the Office of the Health Ombudsman.
How long does an assessment take?
The Board generally aims to complete a preliminary assessment within around 60 days; matters that proceed to investigation take longer.
Will a dispensing error cost me my registration?
Usually not. A one-off error in otherwise sound practice rarely leads to registration action; the Board focuses on whether the underlying cause has been understood and fixed.
Should I get advice before responding?
Yes — contact your indemnity insurer or the Pharmacists' Defence Limited before responding, and avoid informal discussions with investigators; nothing said to an investigator is unrecorded.
Where can I get support?
The Pharmacists' Support Service provides confidential help on 1300 244 910, 8am to 11pm every day.
This article is general information for education and CPD purposes. It is not legal advice and does not create a practitioner–adviser relationship. If you have received a notification, seek advice from your professional indemnity insurer, your union or professional association, or an independent lawyer experienced in health practitioner regulation. Healthcare Ethics Australia is an independent provider of remediation courses, and certificates are issued by Healthcare Ethics Courses. Neither is affiliated with, endorsed by, or acting on behalf of Ahpra or any National Board; regulator names are used for reference only.